Company / Financials
Profound Medical Corp. Financials
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$10.7M
FY2025 · +48.4% YoY
Net Income
-$27.8M
FY2025 · +1.8% YoY
Profit Margin
-260.4%
FY2025 · net income / revenue
ROE
-46.0%
FY2025 · return on equity
Total Assets
$77.5M
FY2025
Total Debt
$4.7M
0.08x debt/equity
Equity
$60.4M
FY2025
ROA
-35.9%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score 0.95 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$10.7M+48.4% YoYNet Income HistoryProfit after all expenses and taxes-$27.8M+1.8% YoYGross Profit HistoryRevenue minus cost of goods sold$7.0M+63.2% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$3.6M+26.2% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$33.1M-15.4% YoYSG&A Expense HistorySelling, general, and administrative expenses$23.1M+24.8% YoYR&D Expense HistoryResearch and development spending$17.0M+17.6% YoYInterest Expense HistoryCost of borrowing and debt obligations$600.0KIncome Tax HistoryTotal income tax expense-$2.0K+98.4% YoYEPS (Basic) HistoryBasic earnings per share$1.12-16.4% YoY